Atlas Trials

Study of Rofecoxib and Prolonged Constant Infusion of Gemcitabine in the Polychemotherapy Treatment of Advanced NSCLC

Clinical trial NCT00385606 · COMPLETED

Trial details

NCT number
NCT00385606
Sponsor
National Cancer Institute, Naples
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Advanced Non-small Cell Lung Cancer
Start date
2003-01-01
Primary completion
2005-12-01
Enrollment
400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.